Cardiovascular Patient Management in the Era of COVID-19Presented by Nihar R. Desai, MD, MPH, Dave L. Dixon, PharmD, Anandita Agarwala Kulkarni, MD, and Sudha Ravilla, MD |
Perspectives on Low-Carbohydrate and Very-Low-Carbohydrate DietsPresented by Daniel Soffer, MD, FNLA, Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA, Kevin Maki, PhD, CLS, FNLA and Margo Minissian, PhD, ACNP, FNLA |
Clinical Utility of Genetic Testing in the Diagnosis of Familial HypercholesterolemiaPresented by Amy C. Sturm, MS, LGC, Peter H. Jones, MD and Alan S. Brown, MD Support provided by Quest Diagnostics |
Recommendations on Treatment with PCSK9 InhibitorsPresented by Carl E. Orringer, MD, FACC, FNLA and Alan S. Brown, MD, FACC, FAHA, FNLA, FASPC |
FOURIER trial: Understanding the Role of PCSK9 Inhibitors in ASCVD PatientsPresented by Daniel Soffer, MD, FNLA, FACP and Alan S. Brown, MD, FACC, FAHA, FNLA, FASPC |
Publish Date:
Friday, May 19, 2017 - 15:30
This page was last updated: May 27, 2020